Technical Analysis for OLMA - Olema Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 8.11 | -2.11% | -0.18 |
OLMA closed down 5.05 percent on Wednesday, November 20, 2024, on 78 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | -2.11% | |
| Lower Bollinger Band Walk | Weakness | -2.11% | |
| New 52 Week Low | Weakness | -2.11% | |
| Wide Bands | Range Expansion | -2.11% | |
| Below Lower BB | Weakness | -2.11% | |
| Lower Bollinger Band Touch | Weakness | -2.11% | |
| Oversold Stochastic | Weakness | -2.11% | |
| Stochastic Buy Signal | Bullish | -7.05% | |
| Lower Bollinger Band Walk | Weakness | -7.05% | |
| Inside Day | Range Contraction | -7.05% |
| Alert | Time |
|---|---|
| 2x Volume Pace | about 1 hour ago |
| 1.5x Volume Pace | about 1 hour ago |
| 60 Minute Opening Range Breakdown | about 3 hours ago |
| Down 5% | about 4 hours ago |
| Down 3% | about 4 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer. Olema is headquartered in San Francisco.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Breast Cancer Treatment Of Breast Cancer Epidermal Growth Factor Receptor Hormones Targeted Therapy Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Selective Estrogen Receptor Degraders Fulvestrant
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Clinical Medicine Breast Cancer Treatment Of Breast Cancer Epidermal Growth Factor Receptor Hormones Targeted Therapy Her2 Her2/Neu Estrogen Antiestrogens Estrogen Receptor Selective Estrogen Receptor Degraders Fulvestrant
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.775 |
| 52 Week Low | 8.12 |
| Average Volume | 460,394 |
| 200-Day Moving Average | 12.02 |
| 50-Day Moving Average | 11.77 |
| 20-Day Moving Average | 11.18 |
| 10-Day Moving Average | 10.54 |
| Average True Range | 0.84 |
| RSI (14) | 23.08 |
| ADX | 20.53 |
| +DI | 14.48 |
| -DI | 36.77 |
| Chandelier Exit (Long, 3 ATRs) | 10.98 |
| Chandelier Exit (Short, 3 ATRs) | 10.65 |
| Upper Bollinger Bands | 13.88 |
| Lower Bollinger Band | 8.48 |
| Percent B (%b) | -0.04 |
| BandWidth | 48.38 |
| MACD Line | -0.80 |
| MACD Signal Line | -0.38 |
| MACD Histogram | -0.4164 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.29 | ||||
| Resistance 3 (R3) | 9.34 | 9.07 | 9.12 | ||
| Resistance 2 (R2) | 9.07 | 8.81 | 9.04 | 9.06 | |
| Resistance 1 (R1) | 8.67 | 8.65 | 8.54 | 8.62 | 9.01 |
| Pivot Point | 8.40 | 8.40 | 8.33 | 8.37 | 8.40 |
| Support 1 (S1) | 8.00 | 8.14 | 7.87 | 7.95 | 7.55 |
| Support 2 (S2) | 7.73 | 7.98 | 7.70 | 7.50 | |
| Support 3 (S3) | 7.33 | 7.73 | 7.44 | ||
| Support 4 (S4) | 7.28 |
